HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
39 hedge funds and large institutions have $9M invested in Hepion Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25% less capital invested
Capital invested by funds: $11.9M → $9M (-$2.93M)
Holders
39
Holding in Top 10
–
Calls
$538K
Puts
$115K
Top Buyers
| 1 | +$79K | |
| 2 | +$57K | |
| 3 | +$57K | |
| 4 |
AC
Aristides Capital
Louisville,
Kentucky
|
+$56K |
| 5 |
PAM
PVG Asset Management
Golden,
Colorado
|
+$54.8K |
Top Sellers
| 1 | -$204K | |
| 2 | -$76K | |
| 3 | -$53K | |
| 4 |
PFS
Prospera Financial Services
Dallas,
Texas
|
-$46K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$45.6K |